Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Atoguanil vs Malarone in Healthy Adults
NCT04866602Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Atoguanil in malaria (2 arms), sponsored by Medicines for Malaria Venture. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-Time Curve from Time Zero to Last Detectable Concentration and 3 more. Started Nov 2021; status: completed.
02
Drugs
Atoguanil
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04866602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04866602.